An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital

[1]  J. Fishman,et al.  Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients , 2004, Clinical Microbiology Reviews.

[2]  G. Peterson,et al.  Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis. , 2004, The Journal of rheumatology.

[3]  J. Byrd,et al.  Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia. , 2004, Clinical lymphoma.

[4]  S. Saravana,et al.  Myelotoxicity due to methotrexate – an iatrogenic cause , 2003, European journal of haematology.

[5]  Fredrick D. Ashbury,et al.  The Impact of Computerized Clinical Reminders on Physician Prescribing Behavior: Evidence From Community Oncology Practice , 2003, American journal of medical quality : the official journal of the American College of Medical Quality.

[6]  C. Langford,et al.  Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse. , 2003, The American journal of medicine.

[7]  S. Grossman,et al.  Pneumocystis carinii pneumonia prophylaxis in HIV negative patients with primary CNS lymphoma. , 2003, Cancer treatment reviews.

[8]  J. Zurlo,et al.  Trimethoprim-sulfamethoxazole revisited. , 2003, Archives of internal medicine.

[9]  M. Robin,et al.  Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  K. Sepkowitz.  Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  C. Dykewicz.  Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  R. Garland,et al.  Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. , 2000, Chest.

[13]  F. Giles,et al.  Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: An international oncology study group (IOSG) phase II protocol , 2000, American journal of hematology.

[14]  M. Andreeff,et al.  Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Vasconcelles,et al.  Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  S. Crawford,et al.  High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. Fishman,et al.  A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation , 1999, Bone Marrow Transplantation.

[18]  W. El-Sadr,et al.  Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group. , 1998, The New England journal of medicine.

[19]  J. B. Castelli,et al.  Primary Pneumocystis carinii Prophylaxis with Aerosolized Pentamidine after Bone Marrow Transplantation , 1998, Acta Haematologica.

[20]  J. Gumpel,et al.  Methotrexate and trimethoprim: a fatal interaction. , 1998, British journal of rheumatology.

[21]  E. Bouza,et al.  Pneumocystis carinii infection in heart transplant recipients. Efficacy of a weekend prophylaxis schedule. , 1997, Medicine.

[22]  M. Kulke,et al.  Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  G. Lemp,et al.  Prevention of Pneumocystis carinii pneumonia: who are we missing? , 1997, AIDS.

[24]  D. Rimland,et al.  Comparison of Trimethoprim‐Sulfamethoxazole, Dapsone, and Pentamidine in the Prophylaxis of Pneumocystis carinii Pneumonia , 1996, Pharmacotherapy.

[25]  J. Montaner,et al.  Adherence to guidelines for the prevention of HIV-related respiratory diseases. , 1996, The European respiratory journal.

[26]  K. High,et al.  Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  K. Sepkowitz.  Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: who should receive prophylaxis? , 1996, Mayo Clinic proceedings.

[28]  S. Yale,et al.  Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. , 1996, Mayo Clinic proceedings.

[29]  K. Sepkowitz,et al.  Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk. , 1995, Archives of internal medicine.

[30]  A. Keating,et al.  Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole. , 1995, Bone Marrow Transplantation.

[31]  P. Thall,et al.  Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  A. Aupérin,et al.  Attitudes to prevention among HIV-infected patients: the case of specific prophylaxis for Pneumocystis carinii pneumonia. , 1994, Health policy.

[33]  K. Sepkowitz.  Pneumocystis carinii pneumonia in patients without AIDS. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  C. Coltman,et al.  Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with acute leukemia: evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veterans Affairs Cooperative Study. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  S. Peters,et al.  Pneumocystis carinii pneumonia and methotrexate therapy. , 1993, Chest.

[36]  Y. Khaliq,et al.  Comparing Pneumocystis carinii pneumonia prophylactic regimens. , 1993, Archives of internal medicine.

[37]  P. Wen,et al.  Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. , 1993, The American journal of medicine.

[38]  J. Govert,et al.  Pancytopenia from using trimethoprim and methotrexate. , 1992, Annals of internal medicine.

[39]  G. Beall,et al.  A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. , 1992, Archives of internal medicine.

[40]  K. Sepkowitz,et al.  Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. , 1992, JAMA.

[41]  B. Coiffier,et al.  Pneumocystis pneumonia in a patient treated with fludarabine for chronic lymphocytic leukemia. , 1991, European journal of cancer.

[42]  G. Koren,et al.  Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia. , 1990, The Journal of pediatrics.

[43]  F. Rampen,et al.  Methotrexate and trimethoprim–sulphamethoxazole—a potentially hazardous combination , 1990, Clinical and experimental dermatology.

[44]  G. Masera,et al.  Prospective randomized comparison of two prophylactic regimens with trimethoprim-sulfamethoxazole in leukemic children: a two year study. , 1987, European journal of cancer & clinical oncology.

[45]  M. Faulkner,et al.  Pneumocystis carinii pneumonia following 5-fluorouracil administration. , 1987, Journal of the National Medical Association.

[46]  M. Schell,et al.  Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. , 1987, The New England journal of medicine.

[47]  L. Robison,et al.  Myelosuppression associated with co-trimoxazole as a prophylactic antibiotic in the maintenance phase of childhood acute lymphocytic leukemia. , 1984, The Journal of pediatrics.

[48]  B. Barlogie,et al.  Effective treatment of advanced multiple myeloma refractory to alkylating agents. , 1984, The New England journal of medicine.

[49]  A. Suffredini,et al.  Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. , 1984, The Journal of infectious diseases.

[50]  W. Woods,et al.  Influence of co‐trimoxazole on methotrexate pharmacokinetics in children with acute lymphoblastic leukemia , 1981, The American journal of pediatric hematology/oncology.

[51]  R. Aur,et al.  Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. , 1977, The New England journal of medicine.

[52]  D. Perl,et al.  Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic, and clinical features. , 1976, National Cancer Institute monograph.

[53]  R. Aur,et al.  Intensity of immunosuppressive therapy and the incidence of pneumocystis carinii pneumonitis , 1975, Cancer.